Emerging research explores how a wearable device may identify infection before symptoms appear, which treatments reduce hospitalizations, and who remains most at risk.
From respiratory syncytial virus monoclonal antibody approvals to thimerosal-free vaccine preferences, ACIP’s latest guidance has important implications for your practice.
Recent studies show distinct metabolic disruptions in children with multisystem inflammatory syndrome in children, plaque progression in adults post–COVID-19, and surprising pneumococcal risk patterns.
...
Recent studies examine potential delays to COVID vaccine updates, variability in pediatric antiviral use, the impact of SARS-CoV-2 on sperm quality, and menstrual cycle changes following vaccination.
The FDA has announced that it will limit access to COVID-19 vaccines, making them only available to high-risk populations. The organization also announced that they will require manufacturers to further...
A 2-year follow-up of the COVAXID trial shows that repeated SARS-CoV-2 mRNA booster doses significantly improve antibody and T cell responses in immunocompromised patients, even among initial poor...
A population-based cohort study found that receiving two or more doses of a COVID-19 vaccine was associated with a significantly lower risk of developing persistent post–COVID condition among individuals...
A recent study examined how prior SARS-CoV-2 vaccination influences innate and adaptive immune responses in breakthrough infections, revealing distinct immune activation patterns.
